Member Info for JohnHenry

Also worth remembering NCYT OXD products work and are selling. TILS at present is an unknown.If 501 doesnt work TILS will plummet.

Spread your risk.

Sam have you actually researched how much revenue the likes of NCYT ODX are potentially going to make.

Markets move through the balance of supply and demand. At present there is simply to much supply for this stock to move higher.

how can they let it go when there are sellers.

Theres nothing deliberate about the spread, the spread is due to only 3 MM covering the stock with a NMS of 3000 shares. Also note before Covid volumes where pitiful a few thousand shares a day. Thats the reason the company wanted to delist from AIM. Due to Covid volumes have increased 1000 fold. On many days there was zero trades. Hopefully with the AIM listing staying more MMs will make a market and the spreads will close.

quite common trading when you have a background seller.

L2 strengthening

Absolutely Trumpton

Citytrader not when you have £10-£15K tranches being dumped every hr

shareseeker TILS have had a few large sellers, placing sellers now ex CLN provider through the warrant conversion.

No idea Sam depends how many they had forward sold before the conversion.

When the warrant holders have cleared their stock.

im guessing u didnt read the article, its a coronavirus test be developed for Africa.

Monologic are a trust non profit making.

At present not confident in an Antibody test they can trust.

PM your posts are becoming absolute garbage as you try desperately to justify your deramping. pathetic.

MMs dont need to shake as weak shirts and skirts sell.

Preliminary analysis of the Phase 2 portion of the trial demonstrated that Kevzara rapidly lowered C-reactive protein, a key marker of inflammation, meeting the primary endpoint (see table below).

spread 57-62p

options to expand the agreement, as manufacturing is scaled up this agreement will be increased imho

43K delayed buy